Nayler WG. Amlodipine. Berlin: Springer-Verlag, 1993.
Donelly R, Meredith PA, Miller SHK et al. Pharmacodynamic modeling of the antihypertensive response to amlodipine. Clin. Pharmacol. Ther., 1993, 54: 303-10.
Bainbridge AD, Herlihy PA, Meredith PA, Elliott HL. A comparative assessment of amlodipine and felodipine ER: pharmacokinetic and pharmacodynamic in incites. Eur.J. Clin. Pharmacol., 1993, 45: 425-30.
Mason RP, Marche P, Hintze TH. Novel Vascular Biology of Third-Generation L-Type Calcium Channel Antagonists: Ancillary Actions of Amlodipine. Arterioscler Thromb Vasc Biol., 2003, 23: 2155-63.
Hernandez RH, Armas-Hernarndez MJ, Zafar HI, Armas-Padilla MC. Calcium antagonists and atherosclerosis protection in hypertension. Am. J. Therap., 2003, 10: 409-14.
Phillips JE, Mason RP. Inhibition of oxidized LDL aggregation with a charged calcium antagonist amlodipine: role of electrostatic interactions. Atherosclerosis, 2003, 168: 239-44.
Mason RP, Walter MF, Trumbore MW et al. Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine. J. Mol. Cell Cardiol., 1999, 31: 275-81.
Batova S, DeWever J, Godfraind T et al. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells. Cardiovascular Research, 2006, 71: 478-85.
Zhang X-P, Xu X, Nasjletti A, Hintze TH. Amlodipine enhances NO production induced by an ACE inhibitor through a kinin-mediated mechanism in canine coronary microvessels.J. Cardiovasc Pharmacol., 2000, 35: 195-202.